Bicara Therapeutics Inc. Payments of Stock Issuance Costs
Bicara Therapeutics Inc. (BCAX) reported Payments of Stock Issuance Costs of $0 for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-03-30
- 2025-06-30: Payments of Stock Issuance Costs 6 month $0.00.
- 2024-09-30: Payments of Stock Issuance Costs 1 month $29.80M.
- 2024-09-13: Payments of Stock Issuance Costs $29.80M.
- 2024-06-30: Payments of Stock Issuance Costs 6 month $596.00K.
| Period end | Payments of Stock Issuance Costs | Payments of Stock Issuance Costs 1 month | Payments of Stock Issuance Costs 6 month |
|---|---|---|---|
| 2025-06-30 | $0.00 10-Q · filed 2025-08-12 | ||
| 2024-09-30 | $29.80M 10-K · filed 2026-03-30 | ||
| 2024-09-13 | $29.80M 10-K · filed 2025-03-27 | ||
| 2024-06-30 | $596.00K 10-Q · filed 2025-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B |